nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Carvedilol—HIF1A—thyroid cancer	0.11	1	CrCbGaD
Methocarbamol—Conjunctivitis—Vandetanib—thyroid cancer	0.0274	0.0308	CcSEcCtD
Methocarbamol—Bradycardia—Vandetanib—thyroid cancer	0.0257	0.0289	CcSEcCtD
Methocarbamol—Dysgeusia—Vandetanib—thyroid cancer	0.0215	0.0242	CcSEcCtD
Methocarbamol—Vision blurred—Vandetanib—thyroid cancer	0.0207	0.0233	CcSEcCtD
Methocarbamol—Loss of consciousness—Vandetanib—thyroid cancer	0.0193	0.0217	CcSEcCtD
Methocarbamol—Convulsion—Vandetanib—thyroid cancer	0.0191	0.0214	CcSEcCtD
Methocarbamol—Jaundice—Sorafenib—thyroid cancer	0.0185	0.0208	CcSEcCtD
Methocarbamol—Nystagmus—Epirubicin—thyroid cancer	0.0176	0.0197	CcSEcCtD
Methocarbamol—Nystagmus—Doxorubicin—thyroid cancer	0.0163	0.0183	CcSEcCtD
Methocarbamol—Insomnia—Vandetanib—thyroid cancer	0.0162	0.0183	CcSEcCtD
Methocarbamol—Flushing—Sorafenib—thyroid cancer	0.0158	0.0178	CcSEcCtD
Methocarbamol—Dyspepsia—Vandetanib—thyroid cancer	0.0158	0.0178	CcSEcCtD
Methocarbamol—Pain—Vandetanib—thyroid cancer	0.0154	0.0173	CcSEcCtD
Methocarbamol—Dysgeusia—Sorafenib—thyroid cancer	0.0145	0.0163	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Epirubicin—thyroid cancer	0.0143	0.016	CcSEcCtD
Methocarbamol—Body temperature increased—Vandetanib—thyroid cancer	0.0142	0.016	CcSEcCtD
Methocarbamol—Angioedema—Sorafenib—thyroid cancer	0.0136	0.0152	CcSEcCtD
Methocarbamol—Syncope—Sorafenib—thyroid cancer	0.0133	0.015	CcSEcCtD
Methocarbamol—Leukopenia—Sorafenib—thyroid cancer	0.0133	0.0149	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.0132	0.0148	CcSEcCtD
Methocarbamol—Loss of consciousness—Sorafenib—thyroid cancer	0.013	0.0147	CcSEcCtD
Methocarbamol—Coordination abnormal—Epirubicin—thyroid cancer	0.0128	0.0144	CcSEcCtD
Methocarbamol—Pruritus—Vandetanib—thyroid cancer	0.0127	0.0143	CcSEcCtD
Methocarbamol—Anaphylactic shock—Sorafenib—thyroid cancer	0.0121	0.0136	CcSEcCtD
Methocarbamol—Shock—Sorafenib—thyroid cancer	0.0119	0.0134	CcSEcCtD
Methocarbamol—Dizziness—Vandetanib—thyroid cancer	0.0119	0.0133	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—thyroid cancer	0.0118	0.0133	CcSEcCtD
Methocarbamol—Vomiting—Vandetanib—thyroid cancer	0.0114	0.0128	CcSEcCtD
Methocarbamol—Rash—Vandetanib—thyroid cancer	0.0113	0.0127	CcSEcCtD
Methocarbamol—Dermatitis—Vandetanib—thyroid cancer	0.0113	0.0127	CcSEcCtD
Methocarbamol—Headache—Vandetanib—thyroid cancer	0.0113	0.0126	CcSEcCtD
Methocarbamol—Nausea—Vandetanib—thyroid cancer	0.0107	0.012	CcSEcCtD
Methocarbamol—Dyspepsia—Sorafenib—thyroid cancer	0.0107	0.012	CcSEcCtD
Methocarbamol—Thrombophlebitis—Epirubicin—thyroid cancer	0.0105	0.0118	CcSEcCtD
Methocarbamol—Pain—Sorafenib—thyroid cancer	0.0104	0.0116	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00974	0.0109	CcSEcCtD
Methocarbamol—Urticaria—Sorafenib—thyroid cancer	0.00962	0.0108	CcSEcCtD
Methocarbamol—Body temperature increased—Sorafenib—thyroid cancer	0.00958	0.0108	CcSEcCtD
Methocarbamol—Diplopia—Epirubicin—thyroid cancer	0.00911	0.0102	CcSEcCtD
Methocarbamol—Hypersensitivity—Sorafenib—thyroid cancer	0.00893	0.01	CcSEcCtD
Methocarbamol—Pruritus—Sorafenib—thyroid cancer	0.00857	0.00963	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—thyroid cancer	0.00843	0.00947	CcSEcCtD
Methocarbamol—Dizziness—Sorafenib—thyroid cancer	0.00801	0.009	CcSEcCtD
Methocarbamol—Vomiting—Sorafenib—thyroid cancer	0.0077	0.00866	CcSEcCtD
Methocarbamol—Rash—Sorafenib—thyroid cancer	0.00764	0.00858	CcSEcCtD
Methocarbamol—Dermatitis—Sorafenib—thyroid cancer	0.00763	0.00858	CcSEcCtD
Methocarbamol—Headache—Sorafenib—thyroid cancer	0.00759	0.00853	CcSEcCtD
Methocarbamol—Nausea—Sorafenib—thyroid cancer	0.0072	0.00809	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—thyroid cancer	0.00702	0.00789	CcSEcCtD
Methocarbamol—Jaundice—Epirubicin—thyroid cancer	0.00684	0.00769	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—thyroid cancer	0.00682	0.00767	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—thyroid cancer	0.0065	0.0073	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—thyroid cancer	0.00642	0.00721	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—thyroid cancer	0.00633	0.00711	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—thyroid cancer	0.00631	0.00709	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—thyroid cancer	0.00594	0.00667	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—thyroid cancer	0.00585	0.00657	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—thyroid cancer	0.00541	0.00608	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—thyroid cancer	0.00537	0.00604	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—thyroid cancer	0.00517	0.00581	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—thyroid cancer	0.00497	0.00559	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—thyroid cancer	0.00493	0.00554	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—thyroid cancer	0.00492	0.00553	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—thyroid cancer	0.00491	0.00552	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—thyroid cancer	0.00482	0.00542	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—thyroid cancer	0.00478	0.00538	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—thyroid cancer	0.00475	0.00534	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—thyroid cancer	0.00456	0.00512	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—thyroid cancer	0.00455	0.00512	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—thyroid cancer	0.00454	0.00511	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—thyroid cancer	0.00451	0.00507	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—thyroid cancer	0.00448	0.00503	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—thyroid cancer	0.00446	0.00501	CcSEcCtD
Methocarbamol—Shock—Epirubicin—thyroid cancer	0.0044	0.00495	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—thyroid cancer	0.0044	0.00494	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—thyroid cancer	0.00418	0.0047	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—thyroid cancer	0.00418	0.00469	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00414	0.00466	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—thyroid cancer	0.00408	0.00458	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—thyroid cancer	0.00405	0.00455	CcSEcCtD
Methocarbamol—Somnolence—Epirubicin—thyroid cancer	0.00398	0.00447	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—thyroid cancer	0.00394	0.00443	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—thyroid cancer	0.00387	0.00435	CcSEcCtD
Methocarbamol—Pain—Epirubicin—thyroid cancer	0.00383	0.0043	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—thyroid cancer	0.00375	0.00421	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—thyroid cancer	0.00369	0.00415	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—thyroid cancer	0.00368	0.00414	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—thyroid cancer	0.00365	0.0041	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—thyroid cancer	0.00356	0.004	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—thyroid cancer	0.00354	0.00398	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—thyroid cancer	0.00354	0.00398	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—thyroid cancer	0.00341	0.00384	CcSEcCtD
Methocarbamol—Hypersensitivity—Epirubicin—thyroid cancer	0.0033	0.00371	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—thyroid cancer	0.00329	0.0037	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—thyroid cancer	0.00327	0.00368	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—thyroid cancer	0.00317	0.00356	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—thyroid cancer	0.00305	0.00343	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—thyroid cancer	0.00296	0.00333	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—thyroid cancer	0.00293	0.00329	CcSEcCtD
Methocarbamol—Vomiting—Epirubicin—thyroid cancer	0.00285	0.0032	CcSEcCtD
Methocarbamol—Rash—Epirubicin—thyroid cancer	0.00282	0.00317	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—thyroid cancer	0.00282	0.00317	CcSEcCtD
Methocarbamol—Headache—Epirubicin—thyroid cancer	0.0028	0.00315	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—thyroid cancer	0.00274	0.00308	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—thyroid cancer	0.00266	0.00299	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—thyroid cancer	0.00263	0.00296	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—thyroid cancer	0.00261	0.00294	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—thyroid cancer	0.00261	0.00293	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—thyroid cancer	0.0026	0.00292	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—thyroid cancer	0.00246	0.00277	CcSEcCtD
